|
Market Closed -
Nasdaq
21:00:00 04/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 1.210 USD | -0.82% |
|
+0.83% | -48.07% |
| 08-12 | Spero Therapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 | |
| 08-12 | Spero Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| SPRO | Delayed | |
CBOE
| SPRO | Real-time | |
Boerse Muenchen
| 2HA | Real-time | |
Tradegate
| 2HA | Real-time | |
Deutsche Boerse AG
| 2HA | Delayed | |
Börse Stuttgart
| 2HA | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Bearish |
| Resistance | 1.27 | 2.02 | 1.87 |
| Spread/Res. | -4.72% | -40.10% | -35.29% |
| Spread/Supp. | +5.22% | +5.22% | +3.42% |
| Support | 1.15 | 1.15 | 1.17 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- SPRO Stock
- Charts Spero Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions

















